{"entity":{"id":"nct07739485","kind":"trial","name":"Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study","aka":["GBCF003"],"tldr":"A phase 1/2 trial of epirubicin in triple-negative breast cancer, run by Liu Shu, now recruiting.","summary":"Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study is a phase 1/2, interventional study registered as NCT07739485 by Liu Shu, with a registry enrolment figure of 30 participants, started 2026-07-30 and due to reach its primary completion in 2027-07-30. Interventions recorded: Epirubicin and cyclophosphamide followed by paclitaxel oral solution. Conditions listed: Triple -Negative Breast Cancer. Triple-negative eligibility wording from the registry: \"Triple-negative breast cancer (TNBC) is defined as ER \\<1%, PR \\<1%, and HER2-negative \\[IHC 0, IHC 1+, or IHC 2+ with FISH-negative\\]\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07739485","url":"https://clinicaltrials.gov/study/NCT07739485"}],"tags":["ctgov-ingest","tnbc-deep-dive"],"related":[],"cancers":["tnbc-early"],"sections":[],"technologies":["cytotoxic-chemotherapy"],"targets":[],"drugs":["epirubicin"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07739485","phase":"1/2","setting":"A Dose-Finding Study of Paclitaxel Oral Solution in Neoadjuvant Therapy for Patients With Triple Negative Breast Cancer","sponsor":"Liu Shu","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07739485/","neighbours":{"cancer":[{"id":"tnbc-early","kind":"cancer","name":"Early triple-negative breast cancer","route":"/cancers/tnbc-early/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"}],"drug":[{"id":"epirubicin","kind":"drug","name":"Epirubicin","route":"/drugs/epirubicin/"}],"term":[{"id":"tnbc-trials-open-today","kind":"term","name":"Triple-negative breast cancer trials open today (registry snapshot and UK sites)","route":"/terms/tnbc-trials-open-today/"}]}}